Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease

Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liyanage, I.K., Niriella, M.A., de Silva, A.P., de Silva, N., de Silva, H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722334/
https://www.ncbi.nlm.nih.gov/pubmed/31616760
http://dx.doi.org/10.14309/crj.0000000000000075
_version_ 1783448513810530304
author Liyanage, I.K.
Niriella, M.A.
de Silva, A.P.
de Silva, N.
de Silva, H.J.
author_facet Liyanage, I.K.
Niriella, M.A.
de Silva, A.P.
de Silva, N.
de Silva, H.J.
author_sort Liyanage, I.K.
collection PubMed
description Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-α therapy.
format Online
Article
Text
id pubmed-6722334
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-67223342019-10-15 Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease Liyanage, I.K. Niriella, M.A. de Silva, A.P. de Silva, N. de Silva, H.J. ACG Case Rep J Case Report Tumor necrosis factor-α inhibitor (TNF-α) is frequently used for Crohn's disease and other autoimmune conditions. Increased risk of infection is an accepted adverse effect of TNF-α, and routine screening for potential infections are carried out before initiation of therapy. We report the case of a patient who developed a localized painful swelling near the injection site, which was diagnosed as acute dermato-lymphangio-adenitis due to filarial infection. This adds to the limited number of case reports on parasitic complications following TNF-α therapy. Wolters Kluwer 2019-06-25 /pmc/articles/PMC6722334/ /pubmed/31616760 http://dx.doi.org/10.14309/crj.0000000000000075 Text en © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Liyanage, I.K.
Niriella, M.A.
de Silva, A.P.
de Silva, N.
de Silva, H.J.
Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title_full Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title_fullStr Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title_full_unstemmed Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title_short Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
title_sort acute dermato-lymphangio-adenitis following administration of infliximab for crohn's disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722334/
https://www.ncbi.nlm.nih.gov/pubmed/31616760
http://dx.doi.org/10.14309/crj.0000000000000075
work_keys_str_mv AT liyanageik acutedermatolymphangioadenitisfollowingadministrationofinfliximabforcrohnsdisease
AT niriellama acutedermatolymphangioadenitisfollowingadministrationofinfliximabforcrohnsdisease
AT desilvaap acutedermatolymphangioadenitisfollowingadministrationofinfliximabforcrohnsdisease
AT desilvan acutedermatolymphangioadenitisfollowingadministrationofinfliximabforcrohnsdisease
AT desilvahj acutedermatolymphangioadenitisfollowingadministrationofinfliximabforcrohnsdisease

Ejemplares similares